Buscar resultados de ensayos clínicos
Cystadenocarcinoma - 74 Studies Found
Estado | Estudiar |
Active, not recruiting |
Nombre del estudio: Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Condición:
Intervenciones: |
Terminated |
Nombre del estudio: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer Condición:
|
Completed |
Nombre del estudio: Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer Condición:
Intervenciones: |
Active, not recruiting |
Nombre del estudio: Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer Condición:
Intervenciones: |
Completed |
Nombre del estudio: TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer Condición:
|
Completed |
Nombre del estudio: Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma Condición:
|
Active, not recruiting |
Nombre del estudio: Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Condición:
|
Completed |
Nombre del estudio: Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer Condición:
|
Recruiting |
Nombre del estudio: Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Condición:
|
Suspended |
Nombre del estudio: Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer Condición:
|